Semisynthetic neoclerodanes as kappa opioid receptor probes

被引:23
|
作者
Lovell, Kimberly M. [1 ]
Vasiljevik, Tamara [1 ]
Araya, Juan J. [1 ]
Lozama, Anthony [2 ]
Prevatt-Smith, Katherine M. [1 ]
Day, Victor W. [1 ]
Dersch, Christina M. [3 ]
Rothman, Richard B. [3 ]
Butelman, Eduardo R. [4 ]
Kreek, Mary Jeanne [4 ]
Prisinzano, Thomas E. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Univ Iowa, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA
[3] NIDA, Clin Psychopharmacol Sect, IRP, DHHS, Baltimore, MD 21224 USA
[4] Rockefeller Univ, Lab Biol Addict Dis, New York, NY USA
基金
美国国家科学基金会;
关键词
Natural product; Salvinorin A; Salvia divinorum; Kappa opioid receptor; Hallucinogen; Furan; SALVINORIN-A; SALVIA-DIVINORUM; NATURAL-PRODUCTS; LIGANDS; AGONIST; TRANSFORMATIONS; IDENTIFICATION; HALLUCINOGEN; ANTAGONISTS; DITERPENES;
D O I
10.1016/j.bmc.2012.02.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as Grignard and Stille conditions, have met with limited success. We report a palladium catalyzed Liebeskind-Srogl cross-coupling reaction of a thioester and a boronic acid that occurs at neutral pH and ambient temperature to produce ketone analogs at C-12. To the best of our knowledge, this is the first reported usage of the Liebeskind-Srogl reaction to diversify a natural product scaffold. We also describe a one-step protocol for the conversion of 1 to 12-epi-1 (3) through microwave irradiation. Previously, this synthetically challenging process has required multiple steps. Additionally, we report in this study that alkene 9 and aromatic analogues 12, 19, 23, 25, and 26 were discovered to retain affinity and selectivity at kappa opioid receptors (KOP). Finally, we report that the furan-2-yl analog of 1 (31) has similar affinity to 1. Collectively, these findings suggest that different aromatic groups appended directly to the decalin core may be well tolerated by KOP receptors, and may generate further ligands with affinity and activity at KOP receptors. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3100 / 3110
页数:11
相关论文
共 50 条
  • [41] The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A
    Ona, Genis
    Sampedro, Frederic
    Romero, Sergio
    Valle, Marta
    Camacho, Valle
    Migliorelli, Carolina
    Angel Mananas, Miguel
    Maria Antonijoan, Rosa
    Puntes, Montserrat
    Coimbra, Jimena
    Rosa Ballester, Maria
    Garrido, Maite
    Riba, Jordi
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (01) : 54 - 63
  • [42] Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues
    Beguin, Cecile
    Potuzak, Justin
    Xu, Wei
    Liu-Chen, Lee-Yuan
    Streicher, John M.
    Groer, Chad E.
    Bohn, Laura M.
    Carlezon, William A., Jr.
    Cohen, Bruce M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1023 - 1026
  • [43] The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
    Clark, Samuel David
    Abi-Dargham, Anissa
    BIOLOGICAL PSYCHIATRY, 2019, 86 (07) : 502 - 511
  • [44] Kappa opioid receptor mediated operant performance in male and female rats
    Namchuk, Amanda B.
    Tsuda, Mumeko C.
    Lucki, Irwin
    Browne, Caroline A.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2024, 244
  • [45] Novel tertiary diarylethylamines as functionally selective agonists of the kappa opioid receptor
    Schrader, Thomas O.
    Lorrain, Kym I.
    Nelli, Matthew R.
    Xue, Yu
    Chen, Yong
    Broadhead, Alexander
    Baccei, Christopher
    Chen, Austin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 120
  • [46] Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist
    McCurdy, CR
    Sufka, KJ
    Smith, GH
    Warnick, JE
    Nieto, MJ
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 83 (01) : 109 - 113
  • [47] Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
    Schmidhammer, Helmut
    Erli, Filippo
    Guerrieri, Elena
    Spetea, Mariana
    MOLECULES, 2020, 25 (21):
  • [48] Structure-Based Design, Synthesis, and Biochemical and Pharmacological Characterization of Novel Salvinorin A Analogues as Active State Probes of the κ-Opioid Receptor
    Yan, Feng
    Bikbulatov, Ruslan V.
    Mocanu, Viorel
    Dicheva, Nedyalka
    Parker, Carol E.
    Wetsel, William C.
    Mosier, Philip D.
    Westkaemper, Richard B.
    Allen, John A.
    Zjawiony, Jordan K.
    Roth, Bryan L.
    BIOCHEMISTRY, 2009, 48 (29) : 6898 - 6908
  • [49] Identification of the three-dimensional pharmacophore of κ-opioid receptor agonists
    Yamaotsu, Noriyuki
    Fujii, Hideaki
    Nagase, Hiroshi
    Hirono, Shuichi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (12) : 4446 - 4452
  • [50] Ligand/kappa-opioid receptor interactions: Insights from the X-ray crystal structure
    Martinez-Mayorga, Karina
    Byler, Kendall G.
    Yongye, Austin B.
    Giulianotti, Marc A.
    Dooley, Colette T.
    Houghten, Richard A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 66 : 114 - 121